Seelos Therapeutics News - SEEL

Company Name	Stock Ticker Symbol	Market	Type
Seelos Therapeutics Inc	SEEL	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	0.3257	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
				0.3257

more quote information »

Recent News

Date	Time	Source	Heading
4/22/2024	8:49	IHNW	FeaturedCannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California
3/06/2024	17:32	EDGAR2	Form S-1/A - General form for registration of securities..
3/06/2024	16:50	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/01/2024	17:39	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/14/2024	16:50	EDGAR2	Form D - Notice of Exempt Offering of Securities
2/06/2024	17:26	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2/02/2024	06:04	EDGAR2	Form S-1 - General form for registration of securities under..
1/30/2024	16:01	EDGAR2	Form 8-K - Current report
1/30/2024	06:05	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
1/22/2024	08:05	EDGAR2	Form 8-K - Current report
1/17/2024	21:47	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/17/2024	21:47	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/10/2024	16:16	EDGAR2	Form 8-K - Current report
1/08/2024	21:46	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/08/2024	21:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/08/2024	21:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/08/2024	21:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/02/2024	08:10	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
12/22/2023	16:01	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
12/22/2023	08:10	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
12/20/2023	16:59	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
12/20/2023	16:54	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
12/18/2023	16:54	EDGAR2	Form S-3 - Registration statement under Securities Act of..
12/15/2023	16:06	EDGAR2	Form DEF 14A - Other definitive proxy statements
12/04/2023	16:05	EDGAR2	Form PRE 14A - Other preliminary proxy statements
12/01/2023	16:16	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/01/2023	16:16	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/01/2023	16:08	EDGAR2	Form 8-K - Current report
11/30/2023	16:59	EDGAR2	Form 8-K - Current report
11/30/2023	16:58	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
11/28/2023	16:06	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
11/28/2023	16:03	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
11/28/2023	09:00	EDGAR2	Form 8-K - Current report
11/24/2023	12:07	EDGAR2	Form 8-K - Current report
11/24/2023	11:10	EDGAR2	Form 8-K - Current report
11/03/2023	16:15	EDGAR2	Form 8-K - Current report
10/02/2023	06:03	EDGAR2	Form 8-K - Current report
9/29/2023	16:56	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
9/25/2023	16:06	EDGAR2	Form 8-K - Current report
9/25/2023	06:02	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
9/20/2023	07:00	EDGAR2	Form 8-K - Current report
9/15/2023	16:01	EDGAR2	Form S-3 - Registration statement under Securities Act of..
9/14/2023	09:00	EDGAR2	Form 8-K - Current report
9/01/2023	16:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/11/2023	16:05	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
6/29/2023	09:00	EDGAR2	Form 8-K - Current report